Generex Biotechnology, a biopharmaceutical company, has named Anthony Crisci as general manager, chief compliance officer, and corporate counsel for all of NuGenerex’s distribution efforts, including its newly acquired eight pharmacies and laboratory from Veneto Holdings, to lead the company in building an end-to-end solution for pharmacy and health management services.

Recently, Crisci was general counsel, chief operating officer, CFO, and controller for a publicly traded holding company, specializing in financial services and technology software companies. Previously, he served as corporate counsel for a major health system with $1 billion in annual revenues, and as general counsel for a national pharmacy benefit management company that includes mail and specialty drug dispensing.

Earlier this year, Generex Biotechnology changed its name to NuGenerex Life Sciences Holdings (NuGenerex) to realize its vision of rebuilding the company as a strategic, diversified life-sciences holding company.